Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beckman Coulter is a global leader in the life sciences and clinical diagnostics industries, providing advanced laboratory instrumentation and reagents for biomedical research and patient care. The company's Biomedical Research division (now part of Beckman Coulter Life Sciences) specializes in tools for cellular analysis, genomics, and laboratory automation, including the Biomek liquid handling platforms and CytoFLEX flow cytometers. Formed through the 1997 merger of Beckman Instruments and Coulter Corporation, the company carries forward the legacy of the Coulter Principle, which revolutionized automated hematology. Today, as a subsidiary of Danaher Corporation, Beckman Coulter supports drug discovery and clinical research across academic, pharmaceutical, and biotechnology sectors worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coulter Biomedical Research.